Hormone replacement therapy (HRT) after breast cancer treatment - Results from an observational study;Hormonersatztherapie (HRT) nach Mammakarzinomerkrankung - Ergebnisse einer Beobachtungsstudie

Geburtshilfe und Frauenheilkunde

Volumn 58, Issue 4, 1998, Pages 193-196

  Beckmann, M W ^a   Mohrmann, T ^a   Kuschel, B ^a   Dadze, A ^a   Mohrmann, S ^a   Dali, P ^a   Nitz, U ^a   Schnuren H G ^a   Bender, H G ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONJUGATED ESTROGEN; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; ESTROGEN RECEPTOR; GOSERELIN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; TAMOXIFEN; TOREMIFENE; TRISEQUENS;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; TREATMENT OUTCOME;

EID: 0031922851     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1022148     Document Type: Article

References (20)

1. Bailar, J. C, H. L Gornik: Cancer undefeated. New Engl. J. Med. 22 (1997)1569-1574.
2. Beckmann, M. W., T. Mohrmann, D. Niederacher: Wirkungsmechanismen von Steroidhormonen und Steroidhormon-Antagonisten und ihre Bedeutung für die Tumorkarzinogenese. Gynäkologe 30 ( 1997) 617-623.
3. Beckmann, M. W.: Bedeutung der Steroidhormone für die Entstehung und Progression von malignen Brustdrüsenveränderungen im Klimakterium und der Postmenopause. J. Menopause 3 (1997) 24-29.
4. Belchetz, P. E.: Hormonal treatment of postmenopausal women. New Engl. J. Med. 330 (1994) 1062-1071.
5. Bonnier, P., S. Romain, P. L Giacalone, F. Laffargue, P. M. Martin, L. Piana: Clinical and biologic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet. Gynecol. 85 (1995) 11-17.
6. Byrne, J., T. R. Fears, H. G. Mitchell. D. Pee, R. R. Connelly, D. F. Austin. G. F. Holmes, F. F. Holmes, H. B. Latourette, J. W. Meiggs, L. C. Strong, M. H. Myers, J. J. Mulvihill: Early menopause in long-term survivors of cancer during adolescence. Amer. J. Obstet. Gynecol. 3 (1992) 788-793.
7. Cobleigh, M. A., R. F. Berris. T. Bush, N. E. Davidson, N. J. Robert, J. A. Sparano, D. C. Tormey, W. C. Wood: Estrogen replacement therapy in breast cancer survivors: A time for change. J. Amer. Med. Assn. 272 (1994) 540.
8. Collaborative Group on hormonal factors in breast cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350 (1997) 1047-1059.
9. Dhodapkar, M. V., J. N. Ingle, D. L Ahmann: Estrogen replacement therapy withdrawal and regression of metastatic breast cancer. Cancer 75 (1995) 43-46.
10. Di Saia, P. J., E. A. Grose, T. Kurosaki, M. Gildea, B. Cowan, H. Anton-Culver: Hormone replacement therapy in breast cancer survivors: A cohort study. Amer. J. Obstet. Gynecol. 147 (1996) 1494-1498.
11. Du Bois, A., H. G. Meerpohl, K. Gerner, H. Prömpeler, W. Vach. U. Aisslinger, M. Breckwoldt, A. Pfleiderer: Einflu einer Schwangerschaft auf Inzidenz und Verlauf von Malignomerkrankungen. Geburtsh. Frauenheilk. 53 (1993) 619-624.
12. Eden, J. A., T. Bush, S. Nand, B. G. Wren: A case-control study of combined continuous estrogen-progestin replacement therapy among women with a personal history of breast cancer. Menopause 2 (1995) 67-72.
13. Grady, D., S. Rubin, D. Petitti, C. S. Fox, D. Black. B. Ettinger, K. L. Ernster, S. R. Cuumings: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Int. Med. 117 (1992) 1016-1036.
14. Grodstein, F., M. J. Stamper, G. A. Colditz, W. C. Willett, J. E. Manson, M. Joffe, B. Rosner, C. Fuchs, S. E. Hankinson, D. J. Hunter, C. H. Hennekens, F. E. Speizer: Postmenopausal hormone therapy and mortality. New Engl. J. Med. 336 (1997) 1769-1775.
15. Jones, C., D. Ingram, E. Mattes, R. Hahnel: The effect of hormone replacement therapy on prognostic indices in women with breast cancer. Med. J. Austral. 161 (1994) 106-110.
16. Magnusson, C., L Holmberg, T. Norden, A. Lindgren, I. Persson: Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res. Treatm. 38 (1996) 325-334.
17. Ortmann, O., K. Diedrich, K. D. Schulz: Hormonelle Substitutionstherapie und gynäkologische Malignome. Gynäkologe 30 (1997) 326-331.
18. Powles, T. J., T. Hickish, S. Casey et al.: Hormone replacement after breast cancer. Lancet 342 (1993) 60-61.
19. Roy, J. A.. C. A. Sawka. K. I. Pritchard: Hormone replacement therapy in women with breast cancer: Do the risks outweight the benefits?]. Gin. Onco!. 14 (1996) 997-1006.
20. Wile, A. G., R. W. Opfell, D. A. Margileth: Hormone replacement therapy in previously treated breast cancer patients. Amer. J. Surg. 165 (1993) 372-375.